paper proposed to use POLY-SVM, RBF-SVM and normalized POLY-SVM method in predicting the drug permeability of BBB which is based on clinical features 29

Markets Europe Markets China Markets Asia Markets World Markets Currencies Prediction Markets Cryptocurrency Futures & Commodities Bonds Funds & ETFs Business Economy Finance Health & Science Media Real Estate Energy Climate Transportation Investigations Industrials Retail Wealth Sports Life Small Business Investing Personal Finance Fintech Financial Advisors Options Action ETF Street Buffett Archive Earnings Trader Talk Tech Cybersecurity AI Enterprise Internet Media Mobile Social Media CNBC Disruptor 50 Tech Guide Politics White House Policy Defense Congress Expanding Opportunity Europe Politics China Politics Asia Politics World Politics Video Latest Video Full Episodes Livestream Top Video Live Audio Europe TV Asia TV CNBC Podcasts CEO Interviews Digital Originals Watchlist Investing Club Trust Portfolio Analysis Trade Alerts Meeting Videos Homestretch Jim's Columns Education Subscribe PRO Pro News Josh Brown Mike Santoli Calls of the Day My Portfolio Livestream Full Episodes Stock Screener Market Forecast Options Investing Chart Investing Subscribe Livestream Make It select USA INTL Livestream Livestream Watchlist SIGN IN Create free account Markets Business Investing Tech Politics Video Watchlist Investing Club PRO Livestream watch now In this video NVO Share Squawk on the Street CNBCs Annika Kim Constantino reports on the FDA's approval of the first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

Learn what they have to say about their GLP1 journeys what worked, what didnt, and how its changed them
Based on the results of your diagnostic tests, we create a personalized wellness plan that addresses various aspects of your health, including sleep, stress, hormones, and overall well-being
Number 1: Lutein and Zeaxanthin are powerful carotenoids that can help protect your eyes from free radicals